Molson Coors Says ‘Volatile Times,’ Not Ozempic, Dim Its Beer Outlook
(Bloomberg) -- Molson Coors Brewing Co.’s more cautious outlook for beer consumption isn’t coming from the new class of weight-loss drugs, which some have speculated would dent the alcohol industry, its chief executive officer said. “We don’t have data to …